YunYi Du, XiaoLing Zhang, Ying Zhang, WeiLing Li, WenQing Hu, Liang Zong, & Jun Zhao. (2022). PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report. Taylor & Francis Group.
Chicago Style (17th ed.) CitationYunYi Du, XiaoLing Zhang, Ying Zhang, WeiLing Li, WenQing Hu, Liang Zong, and Jun Zhao. PD-1 Inhibitor Treatment in a Penile Cancer Patient with MMR/MSI Status Heterogeneity: A Case Report. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationYunYi Du, et al. PD-1 Inhibitor Treatment in a Penile Cancer Patient with MMR/MSI Status Heterogeneity: A Case Report. Taylor & Francis Group, 2022.
Warning: These citations may not always be 100% accurate.